Major indices finish lower amid GE earnings disappointment >>> READ MORE

4 Stocks to Watch on Dendreon Earnings

Other smaller companies could move right along with DNDN

      View All  

Celldex Therapeutics

Click to Enlarge
Market Cap: $215M

Description from Yahoo! Finance

Celldex Therapeutics (NASDAQ:CLDX), a biopharmaceutical company, engages in the development, manufacture and commercialization of novel therapeutics for human healthcare.  The company offers Rotarix for the treatment of rotavirus infection. Its clinical development program includes CDX-110 which is in Phase IIb clinical trial for the treatment of glioblastoma multiforme.

Click to Enlarge
Technical Analysis

The stock also trades nicely above its 50- and 200-day moving averages and finds next support at its 50% and 61.8% retracement levels of its latest upswing. The 61.8% retracement level also coincides with the 50-day moving average.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC